Dr. Armen Yuri Gasparyan has been involved in clinical research on cardiovascular issues in inflammatory rheumatic disorders since 1994, and got his PhD degree in 2002. He was a trainer of English-speaking medical students (2003-2008) and got an academic title of Associate Professor of Medicine in 2006.
Since 2007, he has been working as a research fellow in thrombosis and cardiovascular rheumatology at the Teaching Trusts of the University of Birmingham, UK. As a clinical lecturer, he delivered lectures on the whole course of internal medicine, developed evidence-based clinical guidelines for general practitioners and a textbook on internal medicine. He also developed a set of lectures on clinical rheumatology, science editing, communication, publication ethics and scientometrics and arranged related seminars in the UK, Turkey, Iran, Spain, Kazakhstan and Russia.
He is Visiting Professor at the Kazakh National Medical University (since 2011), Shymkent State Pharmaceutical Academy (since 2014), Dagestan State University (since 2015) and Semey State Medical University (since 2016).
He is a regular reviewer at The Lancet, Journal of the American College of Cardiology, Atherosclerosis, Thrombosis Research, Rheumatology (Oxford), Seminars in Arthritis and Rheumatism, Arthritis Research & Therapy, Clinical Rheumatology, European Journal of Internal Medicine, Inflammation, Therapeutics and Clinical Risk Management, Current Pharmaceutical Design and other high-impact journals.
Dr Gasparyan was elected Adjunct Professor at the Tehran University of Medical Sciences (2010) and Council Member of the European Association of Science Editors (2011-2014).
He is the Chief Editor of the European Science Editing journal (2011-2014), Associate Editor at Rheumatology International (Springer, since 2013), Rheumatology and Editing, Writing & Publishing Sections Editor at the Journal of Korean Medical Science (Seoul, since 2014), Research Integrity Editor at the Mediterranean Journal of Rheumatology, Guest Editor at the Current Pharmaceutical Design (2012 and 2013) and Current Medicinal Chemistry (2014), Deputy Editor-in-Chief of Inflammation & Allergy - Drug Targets (2009-2016), Co-Editor-in-Chief of Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry (since 2016), Science Communication Section Editor at the Croatian Medical Journal (2013-2015), Member of Editorial Boards of Atherosclerosis, Thrombosis Research, Vascular Health & Risk Management, International Journal of the Rheumatic Diseases, Archives of Rheumatology, Anatolian Journal of Cardiology, Current Vascular Pharmacology, Journal of Research in Medical Sciences.
He is a member of the scientific committees at the Excellence in Rheumatology Congress (Madrid, 2012), Eurasian Hematology Congresses (Antalya, 2010, 2012, 2013) and Mediterranean Congress of Rheumatology (Sarajevo, 2016). In 2015, he arranged a special interest group session on ethical journal editing at the British Society of Rheumatology Conference (Manchester, UK).
He joined the World Association of Medical Editors in 2008 and the European Association of Science Editors in 2009. And was appointed as an expert of Scopus Content Selection & Advisory Board (since 2015).